SI
SI
Advertise on SI

 Biotech / Medical | Intuitive Surgical, Inc. (ISRG)


Previous 10 | Next 10 
From: IceHawk2/11/2011 6:15:02 PM
   of 135
 
Intuitive Surgical board OKs $400M share buyback

Considering the float of shares and the average trading volume... thats confidence moving forward.

Share Statistics
Avg Vol (3 month)3: 556,883
Avg Vol (10 day)3: 371,411
Shares Outstanding5: 38.87M
Float: 38.29M
% Held by Insiders6: 1.28%
% Held by Institutions6: 87.50%
Shares Short (as of Jan 14, 2011)3: 2.84M
Short Ratio (as of Jan 14, 2011)3: 6.70
Short % of Float (as of Jan 14, 2011)3: N/A
Shares Short (prior month)3: 2.83M


finance.yahoo.com 

SUNNYVALE, Calif. (AP) -- Intuitive Surgical Inc. said its board has authorized the buyback of up to an additional $298.8 million of the company's outstanding shares, boosting the total available for repurchasing stock to $400 million.

The Sunnyvale, Calif., company, which makes the minimally invasive, robotic da Vinci Surgical Systems, said the timing and repurchase total will depend on market conditions. Intuitive said Tuesday it will fund the repurchase program through cash and investments.

Before the latest increase, there was $101 million unused from previous authorizations.

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)

To: Sam Citron who wrote (59)2/18/2011 12:51:32 AM
From: mrsdalloway   of 135
 
Anyone following MAKO, the knee robotics company?

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)

To: mrsdalloway who wrote (89)2/24/2011 11:31:39 AM
From: turnmore   of 135
 
Yes, looks interesting. What are your thoughts?

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)

To: turnmore who wrote (90)3/5/2011 2:10:18 AM
From: mrsdalloway   of 135
 
I'm starting to follow the discussion on the Fool's NPI thread. Looks a bit richly valued. OTOH, knees are big business, and hips are potentially even bigger!

Below from Denny Schlesinger (captain ccs on Fool).

Currently selling for nearly 10x projected 2011 revenues,

With MAKO at $20 a share:


P/S
ISRG 8.8
MAKO 2010 15.5
MAKO 4Q2010 12.6


MAKO at $14 would be matching ISRG so it's selling at a 43% premium over ISRG.

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)

To: mrsdalloway who wrote (91)3/6/2011 3:43:09 PM
From: turnmore   of 135
 
Yes, I've read all of the recent posts on the NPI board...lots of Gorilla Game terminology that I can't put a good handle on....too much mumbo-jumbo talk for me....I like numbers.

So, as for that,

The numbers DS (captaincc) put up are a bit misleading....he compares current MAKO numbers (a company in the beginning growth stages) to a more mature ISRG....and concludes MAKO is overvalued.

I think if you compare MAKO (now) to ISRG (then...in 2004-2005) you will have a more realistic comparison.....not saying though...that the comparison is justified to start with....????

Two different markets (albeit both, using a robot in the field of medicine...so by default the company's pps should track one another???).

I like reading the posts on the MAKO Board at Investor Village. More info.....less opinion.

Share Recommend | Keep | Reply | Mark as Last Read

From: IceHawk4/6/2011 6:59:25 PM
1 Recommendation   of 135
 
Next big procedure



"Intuitive Surgical has $1.5B opportunity in colorectal, says Collins Stewart
Collins Stewart left the SAGES conference increasingly confident that the next big procedure for Intuitive Surgical's da Vinci system will be colorectal surgery. The firm sees a $1.5B plus market opportunity for Intuitive Surgical in colorectal and reiterates a Buy rating on the stock with a $400 price target. :theflyonthewall.com"

theflyonthewall.com 

Also echoed here:

sumfolio.com 

Share Recommend | Keep | Reply | Mark as Last Read

From: IceHawk10/18/2011 4:34:40 PM
   of 135
 
Intuitive Surgical profits up 41% on higher sales

By Nicole Hong
ISRG

SAN FRANCISCO (MarketWatch) -- Intuitive Surgical Inc. ISRG +7.74% , a robotic surgical systems manufacturer, reported late Tuesday a 41% jump in quarterly profits from a year ago, citing higher da Vinci Surgical System sales. The Sunnyvale, Calif.-based company reported a net income of $122.4 million, or $3.05 a share, up from $86.6 million, or $2.14 a share, a year ago. Third-quarter revenues also rose 30% to $446.7 million from $344.4 million a year earlier. Wall Street analysts had expected earnings of $2.77 a share, on revenue of $417 million, according to a survey by FactSet Research. Intuitive Surgical shares soared 7.1% in after-hours trading on Tuesday. The stock is up 34% over the past 12 months.

marketwatch.com 

Share Recommend | Keep | Reply | Mark as Last Read

From: IceHawk10/18/2011 7:07:29 PM
   of 135
 
Intuitive Surgical 3rd-qtr profit tops expectations


Tue Oct 18, 2011 6:24pm EDT


* Q3 EPS $3.05 vs Wall St view $2.76

* Revenue up 30 percent to $447 million

* 133 da Vinci systems sold in quarter

* Shares rise 7.6 percent

By Bill Berkrot

Oct 18 (Reuters) - Intuitive Surgical Inc reported a much higher-than-expected third-quarter profit on increased demand for its da Vinci surgical robots and a rise in procedures using the expensive systems, and its shares rose nearly 8 percent.

The company sold 133 of its surgical systems in the quarter at a cost of nearly $1.5 million each, and saw procedure volume rise 30 percent in what has been a traditionally weak quarter for Intuitive.

"There was nothing weak about this quarter," said Jason Mills, an analyst for Canaccord Genuity.

While other companies large and small in the sector talk of sluggish demand, "Intuitive Surgical continues to put up great results," Mills said.

The company slightly raised its revenue and procedure growth forecasts for the full year. It now expects 2011 revenue to grow 22 percent to 23 percent, up from a prior view of 19 percent to 21 percent, and sees procedures growing 29 percent to 30 percent, up from its previous forecast of 27 percent to 29 percent.

The company posted a net profit of $122 million, or $3.05 per share, compared with a profit of $87 million, or $2.14 per share, a year ago. That topped analysts' average expectations by 29 cents, according to Thomson Reuters I/B/E/S.

Revenue for the quarter rose 30 percent to $447 million, sailing past Wall Street estimates of $418 million and the previous quarter's sales of $426 million.

"They are performing the best among any company in medical devices. They're the best operators in med tech," Mills said.

The third quarter tends to be weaker for Intuitive as many surgeons who operate the da Vinci systems take vacations during the summer, lowering potential procedure volume.

But procedure volume increased 30 percent over the year-ago quarter. Instruments and accessories sales rose 38 percent to $176 million, and services revenue rose 25 percent to $72 million.

Of the 133 da Vinci systems sold in the quarter, 60 went to repeat customers. The company said 99 systems were sold in the United States, 18 in Europe and 16 in the rest of the world, including six to the potentially lucrative Japanese market for which the company is awaiting reimbursement decisions from regulators.

There are now a total of 2,031 da Vinci systems placed around the world.

The da Vinci systems are most often used in delicate prostate and gynecological procedures and have been associated with shorter hospital stays and fewer complications.

Beyond its traditional surgical areas, the company said it is seeing strong growth in da Vinci use for thoracic and colorectal surgeries and more use in kidney procedures.

"Patients are demanding minimally invasive procedures that get them out of the hospital quicker," Mills said.

The company said it added 76 jobs in the quarter, taking its employee total to 1,845.

Intuitive shares rose 7.6 percent to $412 in extended trading from their Nasdaq close of $382.76.


reuters.com 

Share Recommend | Keep | Reply | Mark as Last Read

From: IceHawk10/19/2011 11:26:24 AM
1 Recommendation   of 135
 



Intuitive Surgical soars on strong earnings report
SAN FRANCISCO (MarketWatch) -- Intuitive Surgical Inc. ISRG +10.17% shares rallied as much as 9.5% in opening trades Wednesday as investors reacted to the company's 41% jump in third-quarter earnings. After the closing bell Tuesday, the robotic surgical equipment maker said it earned $122.4 million, or $3.05 a share, handily topping the $2.77 per-share results analysts were looking for. At last glance, Intuitive Surgical shares were up $36.25, or 9.5%, at $419.01, hitting a fresh 52-week high and landing it among the top percentage gainers in the S&P 500 Index

* Intuitive Surgical price target raised to $475 from $442 at Lazard CapitalIntuitive Surgical price target raised to $475 from $450 at Collins Stewart

* Intuitive Surgical (ISRG) Shares Given New $400.00 Price Target by Bank of America Merrill Lynch Analysts

* Goldman Sachs Raises Price Target On Intuitive Surgical (ISRG), Momentum Unlikely to Reverse. Goldman Sachs raised its price target on Intuitive Surgical (NASDAQ: ISRG) from $362 to $412

* Canaccord Genuity reiterates a 'Hold' on Intuitive Surgical (NASDAQ: ISRG) price target raised to $450.00.

* JP Morgan raises PT on Intuitive Surgical to $370

Share Recommend | Keep | Reply | Mark as Last Read

From: IceHawk10/19/2011 11:27:36 AM
1 Recommendation   of 135
 
Intuitive Surgical climbs on 3Q results, outlookIntuitive Surgical 3rd-quarter results exceed expectations and company raises 2011 estimatesNEW YORK (AP) -- Shares of Intuitive Surgical Inc. jumped Wednesday after the robotic surgical device maker reported strong growth in the third quarter and raised its expectations for 2011.

THE SPARK: Intuitive Surgical said its net income rose 41 percent in the third quarter, to $122.4 million, or $3.05 per share. Its revenue climbed 30 percent to $446.7 million. A year ago, Intuitive Surgical earned $86.6 million, or $2.14 per share, on $344.4 million in revenue.

Analysts had expected net income of $2.77 per share on $417.3 million in revenue, according to FactSet.

Intuitive said it sold 133 da Vinci surgical systems during the quarter, up from 105 a year ago. Revenue from instruments and accessories rose 38 percent to $175.8 million, and revenue from da Vinci system sales grew 25 percent to $199.1 million.

THE BIG PICTURE: The Sunnyvale, Calif., company now says its annual revenue will grow 22 to 23 percent from 2010, which implies a total of $1.72 billion to $1.74 billion. It had forecast growth of 19 to 21 percent. Intuitive Surgical also says procedures performed on the da Vinci system will grow 29 to 30 percent, compared to a previous estimate of 27 to 29 percent.

Analysts expect the company to report $1.7 billion in revenue in 2011, up 20 percent from a year ago.

THE ANALYSIS: William Blair & Co. analyst Ben Andrew said procedure growth was especially strong in international markets. He said the greatest growth overseas came from prostate procedures, while in the U.S., hysterectomy procedures improved. He said procedures should increase 20 to 25 percent through 2015.

"The company has continued to beat expectations for several quarters in a row, which we believe suggests that hospital administrators have turned the corner in beginning to understand the economic benefits and profitability of robotic surgery and should help sustain system sales for some time," Andrew wrote. He kept an "Outperform" rating on the stock.

SHARE ACTION: Intuitive Surgical stock picked up $38.28, or 10 percent, to $421.04 in morning trading. Earlier, the shares reached an all-time high of $421.77.

Share Recommend | Keep | Reply | Mark as Last Read
Previous 10 | Next 10 

Copyright © 1995-2013 Knight Sac Media. All rights reserved.